How has evolution shaped viral infection? How does humanity cope with viral diseases? Why do vaccines work well against one disease but not another? Why are drugs that work against bacteria ineffective against viruses? And how optimistic can we allow ourselves to be about the future? These questions were addressed recently by Dr. Yotam Bar-On of the Ruth and Bruce Rappaport Faculty of Medicine at a Technion event.
Groundbreaking research reveals a self-regulating, implantable living technology that could offer hope for millions with diabetes and other chronic diseases.
The special collaboration will help advance Israeli innovation, energy security, and civil aviation. After concluding the project feasibility study, Boeing and the Technion announced advancement to the next stage of practical development.
Technion has inaugurated a newly upgraded VLSI Laboratory for chip design with a $1 million investment from Apple, Intel and NVIDIA. The facility will support advanced research in integrated circuits, AI-focused hardware and energy-efficient systems while strengthening collaboration between academia and industry.
Technion scientists have developed a pioneering technology that uses harmless live bacteria to produce therapeutic drugs directly inside the body. Delivered via a painless microneedle patch, the bacteria act as tiny drug factories, improving bioavailability and potentially reducing treatment costs and repeated dosing.
Technion researchers have developed SafeWax, a bio-inspired spray coating that forms a thin, biodegradable, water-repellent layer on crops. This innovative technology can reduce the need for chemical pesticides by more than 50%, protect plants from disease and heat stress, and help lower agriculture’s environmental footprint.
World champion windsurfer Linoy Geva has transitioned her discipline and perseverance into academic excellence at Technion. Studying in two elite programs, she combines elite sport spirit with rigorous computer science and leadership training — inspiring peers and promoting women in engineering.
Technion has inaugurated a newly upgraded VLSI Laboratory for chip design with a $1 million investment from Apple, Intel and NVIDIA. The facility will support advanced research in integrated circuits, AI-focused hardware and energy-efficient systems while strengthening collaboration between academia and industry.
A new theoretical breakthrough is reshaping how scientists control heat. By enabling unprecedented manipulation of heat conduction, this research opens the door to smarter thermal management across energy, engineering, and advanced materials.
New Technion research will advance a solution to strokes caused by a blockage of a major brain artery — known as a large vessel occlusion (LVO) — which are medical emergencies. If treatment is delayed, the consequences can be devastating: severe brain damage, disability, or death.
Last week, the Technion marked 25 years since the invention of the portable storage device – the Disk On Key – in a special event with Technion alumnus Dov Moran, the inventor of the USB flash drive.
Technion Researchers reveal complex interactions between heart disease and cancer, in the hope that their findings will lead to improved treatment for both conditions.
